Comprehensive Investigation Of Cannabis Science, A Recurrence Of Misleading Investors And Executive Self-Dealing
Apr 4 2014, 8:25 | by John Brodie Gay | about:CBIS
include:ENDO
Summary
Market Cap of $125M, Total Revenues of $200k, Total Expenses of $87M, Total Operating Deficit of $(90)M, Shareholder Deficit of $(2.96)M.
Series of scattered and unprofitable business endeavors.
History of illegal and deceptive activity among executives.
Insolvency without continued dilution of shares.
Misleading claims with regard to research and development of key flagship products.
